Skip to main content

stock

BOLT · Bolt Biotherapeutics, Inc.

What Bolt Biotherapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live BOLT price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BOLT.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
1,926,345 as of 2026-08-04 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-654.5%
Net
-611.5%

Returns

ROE
-227.4%
ROA
-71.2%

Health

Current ratio
2.6x
Debt/equity
—

Deep value

NCAV
-$7.14M
NCAV per share
-$3.71
Price/NCAV
Locked
NNWC
-$14.84M
NNWC per share
-$7.71
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$5,000—Gross profit: unreported by this company.-$8.37M-$7.72M
10-Q filed 2026-08-11
2026-03-31$26,000—Gross profit: unreported by this company.-$7.60M-$7.24M
10-Q filed 2026-05-12
2025-12-31$2.50M—Gross profit: unreported by this company.-$7.08M-$6.63M
10-K filed 2026-03-12
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$2.17M—Gross profit: unreported by this company.-$7.70M-$7.14M
10-Q filed 2025-11-12
2025-06-30$1.80M—Gross profit: unreported by this company.-$9.21M-$8.56M
10-Q filed 2026-08-11
2025-03-31$1.22M—Gross profit: unreported by this company.-$12.12M-$11.04M
10-Q filed 2026-05-12
2024-12-31$0—Gross profit: unreported by this company.-$16.92M-$15.94M
10-K filed 2026-03-12
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$1.14M—Gross profit: unreported by this company.-$16.44M-$15.18M
10-Q filed 2025-11-12
Assets
$40.34M
Equity
$12.64M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$7.70M-$36.11M-$33.38M-$39.92M
2024-12-31$7.69M-$73.05M-$63.12M-$61.33M
2023-12-31$7.88M-$76.20M-$69.20M-$69.73M
2022-12-31$5.73M-$90.32M-$88.10M-$78.46M
2021-12-31$1.26M-$92.79M-$98.59M-$59.40M
2020-12-31$231,000-$49.18M-$60.73M-$50.57M

Company filings

events

  • Results

    Results
    Aug 118-K
  • Shareholder vote results

    Shareholder vote results
    Jun 118-K
  • Results

    Results
    May 128-K
  • Results

    Results
    Mar 128-K
  • Results

    Results
    11/12/20258-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Yonehiro Grant

    Chief Operating Officer

    Sale$43,807

    Sep 21, 6:05 PM ET

  • Nemec Sarah

    Senior VP, Finance and PAO

    Sale$26,072

    Sep 21, 6:04 PM ET

  • Nemec Sarah

    Senior VP, Finance and PAO

    Buy$1,973

    Sep 21, 6:04 PM ET

  • Quinn William P.

    President, CEO and CFO, Director

    Sale$58,402

    Sep 21, 6:03 PM ET

  • Quinn William P.

    President, CEO and CFO, Director

    Buy$2,469

    Sep 21, 6:03 PM ET

All insider trades for BOLT

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named BOLT, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about BOLT.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about BOLT.

nakagai

Signals on BOLT come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BOLT board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Bolt Biotherapeutics, Inc. (BOLT): SEC filings, financials and insider trades · Nakagai